Research on spatial multi-omics technologies is being applied to gastric cancer, with potential applications in precision drug discovery and tumor immunotherapy. The use of artificial intelligence and machine learning is also being explored in this context, including the integration of cross-sample and cross-modal data. Studies are investigating the role of multi-omics in understanding the tumor microenvironment and immune system interactions, with implications for immune checkpoint inhibitor therapy and other treatments.